Company Overview of Ogenx Therapeutics Corporation, Inc.
Ogenx Therapeutics Corporation, Inc. operates as a clinical development stage company that develops proprietary drugs. It develops drugs with focus on treatment for the dry form of age-related macular degeneration. The company has partnership with Quintiles, Covance, PharmaCore, and Althea. Ogenx Therapeutics Corporation, Inc. was incorporated in 2012 and is based in Clearwater., Florida.
1290 Gulf Boulevard
Clearwater, FL 33767
Founded in 2012
Key Executives for Ogenx Therapeutics Corporation, Inc.
Ogenx Therapeutics Corporation, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Ogenx Therapeutics Corporation, Inc., please visit www.ogenx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.